Durect
Corporation About
Durect Corp. DURECT
Corporation is an emerging specialty pharmaceutical company focused on the development
of pharmaceutical systems based on its proprietary drug delivery platform technologies
that treat chronic debilitating diseases and enable biotechnology products. These
platform technologies include the SABER™ Delivery System (a patented and
versatile depot injectable useful for proteins, peptides and small molecule delivery),
the ORADUR™ sustained release oral gel-cap technology (an oral sustained
release technology with several potential abuse deterrent properties), the DURIN™
Biodegradable Implant (drug-loaded implant system) and the MICRODUR™ Biodegradable
Microparticulates (microspheres injectable system). Post-Operative
Pain Depot --Bupivacaine Transdermal Sufentanil Patch Remoxy™ --Chronic
Pain CHRONOGESIC®
--Chronic Pain Product: DURIN-Leuprolide
-- Alzheimer’s Disease
More on Durect Corporation